Steven H. Bernstein

Steven H. Bernstein

Chief Tech/Sci/R&D Officer chez 2SEVENTY BIO, INC.

Health Technology
Consumer Services
Health Services

Profil

Steven H.
Bernstein
is currently the Chief Medical Officer at 2seventy Bio, Inc. He previously worked as the Chairman of Immuno-Oncology Translational Research at Bristol Myers Squibb Co., a Professor of Medicine and Co-Director of Hematological at James P.
Wilmot Cancer Center, a Member of Lymphoma Working Group at SWOG, and the Chief Translational Officer at Turnstone Biologics Corp.
He received his undergraduate degree from Brandeis University and his doctorate from New York University School of Medicine.

Postes actifs de Steven H. Bernstein

SociétésPosteDébut
2SEVENTY BIO, INC. Chief Tech/Sci/R&D Officer 14/02/2022
Tous les postes actifs de Steven H. Bernstein

Anciens postes connus de Steven H. Bernstein

SociétésPosteFin
Corporate Officer/Principal -
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
James P. Wilmot Cancer Center Corporate Officer/Principal -
TURNSTONE BIOLOGICS CORP. Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Steven H. Bernstein

Formation de Steven H. Bernstein

Brandeis University Undergraduate Degree
New York University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Steven H. Bernstein

Relations

15

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

TURNSTONE BIOLOGICS CORP.

Health Technology

2SEVENTY BIO, INC.

Health Technology

Entreprise privées2
James P. Wilmot Cancer Center

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Steven H. Bernstein